F637-0613 Screening compound: 1-[4-(5-ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide

F637-0613 Screening compound: 1-[4-(5-ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide
F637-0613 Screening compound: 1-[4-(5-ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F637-0613
1-[4-(5-ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F637-0613

Molecular Formula

C22H21N5O2 (C22 H21 N5 O2)

Compound Name

1-[4-(5-ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide

IUPAC name

1-[4-(5-ethyl-124-oxadiazol-3-yl)phenyl]-3-methyl-N-(3-methylphenyl)-1H-pyrazole-4-carboxamide

SMILES

CCc1nc(-c(cc2)ccc2-n2nc(C)c(C(Nc3cc(C)ccc3)=O)c2)no1

InChI

InChI=1S/C22H21N5O2/c1-4-20-24-21(26-29-20)16-8-10-18(11-9-16)27-13-19(15(3)25-27)22(28)23-17-7-5-6-14(2)12-17/h5-13H,4H2,1-3H3,(H,23,28)

InChI Key

YDKITPPHGIRMDF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27180780

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

387.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.619

Distribution Coefficient, logD

4.619

Water Solubility, LogSw

-4.22

Polar Surface Area

69.383

Acid Dissociation Constant (pKa)

11.61

Base Dissociation Constant (pKb)

-2.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

F637-0613 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F637-0613 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F637-0613?
Check Price and Availability of F637-0613, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F637-0613 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F637-0613
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F637-0613
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F637-0613 available by request